Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.

Abstract

Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable alternative to vitamin K antagonists in randomized controlled trials.

Journal

Journal ID (iso-abbrev): Heart Rhythm

Title: Heart rhythm

Publisher: Elsevier BV

ISSN (Electronic): 1556-3871

ISSN (Print): 1547-5271

Publication date (Electronic): September 2017

Volume: 14

Issue: 9

Affiliations

[1 ] St. Antonius Ziekenhuis Nieuwegein/AMC, Amsterdam, The Netherlands. Electronic address: [e-mail].

[2 ] Vivantes Klinikum Urban, Berlin, Germany.

[3 ] Vivantes Klinikum im Friedrichshain, Berlin, Germany.

[4 ] State Research Institute of Circulation Pathology, Novosibirsk, Russia.

[5 ] Elisabeth Krankenhaus Essen, Essen, Germany.

[6 ] Cardioangiologisches Centrum Bethanien, Frankfurt/Main, Germany.

[7 ] Universitätsmedizin Mainz und DZHK Standort Rhein-Main, Mainz, Germany.

[8 ] Asklepios Klinik St Georg, Cardiology, Hamburg, Germany.

[9 ] Cardiovascular Center of Regional State Hospital, Krasnoyarsk, Russia.

[10 ] Oxford University Hospitals NHS Trust, Oxford, United Kingdom.

[11 ] Beaumont Hospital, Dublin, Ireland.

[12 ] CardioVascular Center Frankfurt, Frankfurt, Germany.

[13 ] Ospedale San Raffaele, Milan, Italy.

[14 ] Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium.

[15 ] Boston Scientific, Diegem, Belgium.

[16 ] Boston Scientific, St. Paul, Minnesota.

[17 ] Cardiologicum, Hamburg, Germany.

Article

Publisher Item ID: S1547-5271(17)30715-4

DOI: 10.1016/j.hrthm.2017.05.038

PubMed ID: 28577840